In addition to weight loss, GLP-1s appear to reduce inflammation, depression and suicidality, and improve cardio health
J Am Coll Nutr 10: 1-12
This drew a laugh from my many peers observing me
The two studies by Jensterle et al
John Rush has received consulting fees from Compass Inc., Curbstone Consultant LLC, Emmes Corp., Evecxia Therapeutics, Inc., Holmusk Technologies, Inc., ICON, PLC, Johnson and Johnson (Janssen), Liva-Nova, MindStreet, Inc., Neurocrine Biosciences Inc., Otsuka-US
Clinical trial averages show semaglutide users losing 10-15% of body weight over 68 weeks, and tirzepatide users losing 15-22% of body weight over 72 weeks